110 related articles for article (PubMed ID: 38734900)
21. In vivo analysis of replication and immunogenicity of proviral clones of human T-lymphotropic virus type 1 with selective envelope surface-unit mutations.
Silverman LR; Phipps AJ; Montgomery A; Fernandez S; Tsukahara T; Ratner L; Lairmore MD
Blood; 2005 Nov; 106(10):3602-8. PubMed ID: 16046523
[TBL] [Abstract][Full Text] [Related]
22. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
23. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
24. Pseudotyping of HIV-1 with Human T-Lymphotropic Virus 1 (HTLV-1) Envelope Glycoprotein during HIV-1-HTLV-1 Coinfection Facilitates Direct HIV-1 Infection of Female Genital Epithelial Cells: Implications for Sexual Transmission of HIV-1.
Tang Y; George AM; Petrechko O; Nouvet FJ; Sweet SD; Tanaka Y; Imbiakha BS; Jiang G; Gao W; Anastos K; Hildreth JEK
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624497
[TBL] [Abstract][Full Text] [Related]
25. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant.
Barnett SW; Burke B; Sun Y; Kan E; Legg H; Lian Y; Bost K; Zhou F; Goodsell A; Zur Megede J; Polo J; Donnelly J; Ulmer J; Otten GR; Miller CJ; Vajdy M; Srivastava IK
J Virol; 2010 Jun; 84(12):5975-85. PubMed ID: 20392857
[TBL] [Abstract][Full Text] [Related]
26. The neutralizing function of the anti-HTLV-1 antibody is essential in preventing in vivo transmission of HTLV-1 to human T cells in NOD-SCID/γcnull (NOG) mice.
Saito M; Tanaka R; Fujii H; Kodama A; Takahashi Y; Matsuzaki T; Takashima H; Tanaka Y
Retrovirology; 2014 Aug; 11():74. PubMed ID: 25163482
[TBL] [Abstract][Full Text] [Related]
27. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency.
Pal R; Venzon D; Letvin NL; Santra S; Montefiori DC; Miller NR; Tryniszewska E; Lewis MG; VanCott TC; Hirsch V; Woodward R; Gibson A; Grace M; Dobratz E; Markham PD; Hel Z; Nacsa J; Klein M; Tartaglia J; Franchini G
J Virol; 2002 Jan; 76(1):292-302. PubMed ID: 11739694
[TBL] [Abstract][Full Text] [Related]
28. Impact of T
Verma A; Schmidt BA; Elizaldi SR; Nguyen NK; Walter KA; Beck Z; Trinh HV; Dinasarapu AR; Lakshmanappa YS; Rane NN; Matyas GR; Rao M; Shen X; Tomaras GD; LaBranche CC; Reimann KA; Foehl DH; Gach JS; Forthal DN; Kozlowski PA; Amara RR; Iyer SS
J Virol; 2020 Feb; 94(6):. PubMed ID: 31827000
[TBL] [Abstract][Full Text] [Related]
29. CD8 T Cells Show Protection against Highly Pathogenic Simian Immunodeficiency Virus (SIV) after Vaccination with SIV Gene-Expressing BCG Prime and Vaccinia Virus/Sendai Virus Vector Boosts.
Kato S; Shida H; Okamura T; Zhang X; Miura T; Mukai T; Inoue M; Shu T; Naruse TK; Kimura A; Yasutomi Y; Matsuo K
J Virol; 2021 Jan; 95(4):. PubMed ID: 33087465
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of CD8+ T-cell and antibody responses following transient increased viraemia in rhesus macaques infected with live, attenuated simian immunodeficiency virus.
Metzner KJ; Moretto WJ; Donahoe SM; Jin X; Gettie A; Montefiori DC; Marx PA; Binley JM; Nixon DF; Connor RI
J Gen Virol; 2005 Dec; 86(Pt 12):3375-3384. PubMed ID: 16298985
[TBL] [Abstract][Full Text] [Related]
31. Effect of CD8+ lymphocyte depletion on virus containment after simian immunodeficiency virus SIVmac251 challenge of live attenuated SIVmac239delta3-vaccinated rhesus macaques.
Schmitz JE; Johnson RP; McClure HM; Manson KH; Wyand MS; Kuroda MJ; Lifton MA; Khunkhun RS; McEvers KJ; Gillis J; Piatak M; Lifson JD; Grosschupff G; Racz P; Tenner-Racz K; Rieber EP; Kuus-Reichel K; Gelman RS; Letvin NL; Montefiori DC; Ruprecht RM; Desrosiers RC; Reimann KA
J Virol; 2005 Jul; 79(13):8131-41. PubMed ID: 15956558
[TBL] [Abstract][Full Text] [Related]
32. Neutralizing-antibody-independent SARS-CoV-2 control correlated with intranasal-vaccine-induced CD8
Ishii H; Nomura T; Yamamoto H; Nishizawa M; Thu Hau TT; Harada S; Seki S; Nakamura-Hoshi M; Okazaki M; Daigen S; Kawana-Tachikawa A; Nagata N; Iwata-Yoshikawa N; Shiwa N; Suzuki T; Park ES; Ken M; Onodera T; Takahashi Y; Kusano K; Shimazaki R; Suzaki Y; Ami Y; Matano T
Cell Rep Med; 2022 Feb; 3(2):100520. PubMed ID: 35233545
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
[TBL] [Abstract][Full Text] [Related]
34. T
Helmold Hait S; Hogge CJ; Rahman MA; Hunegnaw R; Mushtaq Z; Hoang T; Robert-Guroff M
Front Immunol; 2020; 11():608003. PubMed ID: 33584682
[TBL] [Abstract][Full Text] [Related]
35. Subunit vaccine protects Macaca nemestrina (pig-tailed macaque) against simian T-cell lymphotropic virus type I challenge.
Dezzutti CS; Frazier DE; Huff LY; Stromberg PC; Olsen RG
Cancer Res; 1990 Sep; 50(17 Suppl):5687S-5691S. PubMed ID: 2167165
[TBL] [Abstract][Full Text] [Related]
36. HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.
Wang Y; O'Dell S; Turner HL; Chiang CI; Lei L; Guenaga J; Wilson R; Martinez-Murillo P; Doria-Rose N; Ward AB; Mascola JR; Wyatt RT; Karlsson Hedestam GB; Li Y
J Virol; 2017 Nov; 91(21):. PubMed ID: 28835491
[TBL] [Abstract][Full Text] [Related]
37. Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (
Shafifar M; Mozhgani SH; Razavi Pashabayg K; Mosavat A; Karbalaei M; Norouzi M; Rezaee SA
Life Sci; 2022 Nov; 308():120920. PubMed ID: 36044973
[TBL] [Abstract][Full Text] [Related]
38. V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques.
Styles TM; Gangadhara S; Reddy PBJ; Sahoo A; Shiferaw A; Welbourn S; Kozlowski PA; Derdeyn CA; Velu V; Amara RR
Front Immunol; 2022; 13():914969. PubMed ID: 35935987
[TBL] [Abstract][Full Text] [Related]
39. Elimination of human T cell leukemia virus type-1-infected cells by neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies against human t cell leukemia virus type-1 envelope gp46.
Tanaka Y; Takahashi Y; Tanaka R; Kodama A; Fujii H; Hasegawa A; Kannagi M; Ansari AA; Saito M
AIDS Res Hum Retroviruses; 2014 Jun; 30(6):542-52. PubMed ID: 24524420
[TBL] [Abstract][Full Text] [Related]
40. Antibody responses to the env epitopes of human T-lymphotropic virus type I in rhesus macaques' naturally infected with simian T-lymphotropic virus type I.
Rudolph DL; Yee J; Palker T; Coligan JE; Lal RB
Res Virol; 1993; 144(3):193-9. PubMed ID: 8395074
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
